NTPDase1 Controls IL-8 Production by Human Neutrophils
- 15 July 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 187 (2) , 644-653
Abstract
The ectonucleotidase NTPDase1 (CD39) terminates P2 receptor activation by the hydrolysis of extracellular nucleotides (i.e., the P2 receptor ligands). In agreement with that role, exacerbated inflammation has been observed in NTPDase1-deficient mice. In this study, we extend these observations by showing that inhibition of NTPDase1 markedly increases IL-8 production by TLR-stimulated human neutrophils. First, immunolabeling of human blood neutrophils and neutrophil-like HL60 cells displayed the expression of NTPDase1 protein, which correlated with the hydrolysis of ATP at their surface. NTPDase1 inhibitors (e.g., NF279 and ARL 67156) as well as NTPDase1-specific small interfering RNAs markedly increased IL-8 production in neutrophils stimulated with LPS and Pam3CSK4 (agonists of TLR4 and TLR1/2, respectively) but not with flagellin (TLR5) and gardiquimod (TLR7 and 8). This increase in IL-8 release was due to the synergy between TLRs and P2 receptors. Indeed, ATP was released from neutrophils constitutively and accumulated in the medium upon NTPDase1 inhibition by NF279. Likewise, both human blood neutrophils and neutrophil-like HL60 cells produced IL-8 in response to exogenous nucleotides, ATP being the most potent inducer. In agreement, P2Y2 receptor knockdown in neutrophil-like HL60 cells markedly decreased LPS- and Pam3CSK4-induced IL-8 production. In line with these in vitro results, injection of LPS in the air pouches of NTPDase1-deficient mice triggered an increased production of the chemokines MIP-2 and keratinocyte-derived chemokine (i.e., the rodent counterparts of human IL-8) compared with that in wild-type mice. In summary, NTPDase1 controls IL-8 production by human neutrophils via the regulation of P2Y2 activation.Keywords
This publication has 55 references indexed in Scilit:
- NTPDase1 governs P2X7‐dependent functions in murine macrophagesEuropean Journal of Immunology, 2010
- CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel diseaseProceedings of the National Academy of Sciences, 2009
- Self-regulation of inflammatory cell trafficking in mice by the leukocyte surface apyrase CD39Journal of Clinical Investigation, 2009
- Central role of Sp1-regulated CD39 in hypoxia/ischemia protectionBlood, 2009
- Ecto-nucleoside Triphosphate Diphosphohydrolase 1 (E-NTPDase1/CD39) Regulates Neutrophil Chemotaxis by Hydrolyzing Released ATP to AdenosineJournal of Biological Chemistry, 2008
- Specificity of the ecto‐ATPase inhibitor ARL 67156 on human and mouse ectonucleotidasesBritish Journal of Pharmacology, 2007
- P2 purinergic receptor modulation of cytokine productionPurinergic Signalling, 2007
- CD39/NTPDase-1 activity and expression in normal leukocytesThrombosis Research, 2007
- International Union of Pharmacology LVIII: Update on the P2Y G Protein-Coupled Nucleotide Receptors: From Molecular Mechanisms and Pathophysiology to TherapyPharmacological Reviews, 2006
- Comparative hydrolysis of P2 receptor agonists by NTPDases 1, 2, 3 and 8Purinergic Signalling, 2005